ASPIRE VT 1

• Research type

  Research Study

• Full title

  Assessment of the Psychosocial morbidity of patients with an implantable cardiac device

• IRAS ID

  301563

• Contact name

  Tarvinder Dhanjal

• Contact email

  tarv.dhanjal@uhcw.nhs.uk

• Sponsor organisation

  University Hospital Coventry and Warwickshire

• Clinicaltrials.gov Identifier

  N/A, N/A

• Duration of Study in the UK

  0 years, 7 months, 1 days

• Research summary

  Why is this study important?
  Patients living with an implantable cardioverter defibrillator often exhibit psychological distress, quantifying this and looking for correlations could help inform clinical practice and improve patients quality of life.
  
  What is being studied?
  Assessing the health-related quality of life of patients living with an implantable cardioverter defibrillator. Specific questionnaires will be used to measure the health-realted quality of life along with specific ICD concerns and bod image concerns.
  
  Who is eligible
  All patients with an ICD in situ, under regular follow up at university hospitals Coventry and Warwickshire, who are between the ages of 18-100 years old

  How long will it last?
  Participants will be asked to fill in one set of questionnaires only, when these are received this marks the end of the study for the participant. There are 6 questionnaires in total these will take up to 30mins to complete

  What are the benefits?
  Understanding psychological distress relating to ICDs will greatly help inform clinical practice. For patients, this greater understanding will shape their treatment plan with the aim of improving their quality of life.

• REC name

  South Central - Oxford A Research Ethics Committee

• REC reference

  21/SC/0328

• Date of REC Opinion

  27 Sep 2021

• REC opinion

  Favourable Opinion